Acusensus (ASX:ACE) Notes Receivable: A$0.00 Mil (As of Dec. 2025)


ASX:ACE Acusensus Ltd ASX:ACE
59 GF Score
Price A$1.17
GF Value A$1.47
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Acusensus Notes Receivable?

Acusensus ASX:ACE -1.69% 59 Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:ACE with a GF Score™ of 59/100 and a GF Value™ of A$1.47 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Acusensus's Notes Receivable for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Acusensus Notes Receivable Historical Data

* Premium members only.

The historical data trend for Acusensus's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusensus Notes Receivable Chart

Acusensus Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Notes Receivable
0.00 0.00 0.00 0.00

Acusensus Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:ACE
59GF Score
Acusensus Ltd ASX:ACE
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acusensus Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of A$0.00 Mil mean?
Acusensus (ASX:ACE) has a Notes Receivable of A$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Acusensus and its competitors.
Is Acusensus' Notes Receivable too high?
Acusensus' current Notes Receivable is A$0.00 Mil. Overall, Acusensus has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acusensus' Notes Receivable compare to MSFT and ORCL?
Acusensus' Notes Receivable of A$0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Software company?
A good Notes Receivable depends on the Software industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Acusensus and its competitors. Acusensus's current Notes Receivable is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.47, compared to a current price of A$1.17 — trading 20.7% below its estimated fair value. The current Notes Receivable is A$0.00 Mil. Acusensus' overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acusensus (ASX:ACE) Overvalued in 2026?

Based on GuruFocus' analysis, Acusensus stock appears to be undervalued. The current stock price of A$1.17 is trading 20.7% below its estimated GF Value™ of A$1.47. GuruFocus considers Acusensus to be Modestly Undervalued.

Key valuation signals for ASX:ACE:

  • Notes Receivable: A$0.00 Mil
  • GF Value™: A$1.47 vs. price of A$1.17 (20.7% below fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acusensus Business Description

Address 31 Queen Street, Level 1, Melbourne, VIC, AUS, 3000
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
59GF Score

Get the complete analysis for ASX:ACE

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.17
Price
A$1.47
GF Value